Dexcom Reports Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. AXP
7. TMUS
8. SPY
9. CVS
10. UNH

Go back to Dexcom Reports Second Quarter 2022 Financial Results

DexCom (DXCM) PT Lowered to $105 at Oppenheimer; 'Buying on Weakness'

July 29, 2022 7:25 AM EDT

Oppenheimer analyst Steven Lichtman lowered the price target on DexCom (NASDAQ: DXCM) to $105.00 (from $525.00) while maintaining an Outperform rating following weak results. The analyst is buying on weakness.

The analyst commented, "DexCom's 2Q22 sales of $696.2M (+17% y/y) slightly lagged our/Street's... More

DexCom (DXCM) Misses Q2 EPS by 2c

July 28, 2022 4:04 PM EDT

DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million.

GUIDANCE:

DexCom sees Q3 2022 revenue of $2.86-2.91 billion, versus the consensus of $2.92... More